M
Marije Vonk Noordegraaf-Schouten
Publications - 6
Citations - 611
Marije Vonk Noordegraaf-Schouten is an academic researcher. The author has contributed to research in topics: Latent tuberculosis & Tuberculosis. The author has an hindex of 5, co-authored 6 publications receiving 514 citations.
Papers
More filters
Journal ArticleDOI
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Haileyesus Getahun,Alberto Matteelli,Ibrahim Abubakar,Mohamed Abdel Aziz,Annabel Baddeley,Draurio Barreira,Saskia Den Boon,Susana Marta Borroto Gutierrez,Judith Bruchfeld,Erlina Burhan,Solange Cavalcante,Rolando Cedillos,Richard E. Chaisson,Cynthia B.E. Chee,Lucy Chesire,Elizabeth L. Corbett,Masoud Dara,Justin T Denholm,Gerard De Vries,Dennis Falzon,Nathan Ford,Margaret Gale-Rowe,Chris Gilpin,Enrico Girardi,Un Yeong Go,Darshini Govindasamy,Alison D. Grant,Malgorzata Grzemska,Ross J Harris,C. Robert Horsburgh,Asker Ismayilov,Ernesto Jaramillo,Sandra V. Kik,Katharina Kranzer,Christian Lienhardt,Philip A. LoBue,Knut Lönnroth,Guy B. Marks,Dick Menzies,Giovanni Battista Migliori,Davide Mosca,Ya Diul Mukadi,Alwyn Mwinga,Lisa J. Nelson,Nobuyuki Nishikiori,Anouk M. Oordt-Speets,Molebogeng Xheedha Rangaka,Andreas Reis,Lisa D. Rotz,Andreas Sandgren,Monica Sañé Schepisi,Holger J. Schünemann,Surender Kumar Sharma,Giovanni Sotgiu,Helen R. Stagg,Timothy R. Sterling,Tamara Tayeb,Mukund Uplekar,Marieke J. van der Werf,Wim Vandevelde,Femke van Kessel,Anna H. van’t Hoog,Jay K. Varma,Natalia Vezhnina,Constantia Voniatis,Marije Vonk Noordegraaf-Schouten,Diana Weil,Karin Weyer,Robert J. Wilkinson,Takashi Yoshiyama,Jean-Pierre Zellweger,Mario C. Raviglione +71 more
TL;DR: The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation and patients with silicosis.
Journal ArticleDOI
Initiation and completion rates for latent tuberculosis infection treatment: a systematic review
Andreas Sandgren,Marije Vonk Noordegraaf-Schouten,Femke van Kessel,Anke L. Stuurman,Anouk M. Oordt-Speets,Marieke J. van der Werf +5 more
TL;DR: Initiation and completion rates for LTBI treatment regimens were frequently suboptimal and varied greatly within and across different populations.
Journal ArticleDOI
Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review
Anke L. Stuurman,Marije Vonk Noordegraaf-Schouten,Femke van Kessel,Anouk M. Oordt-Speets,Andreas Sandgren,Marieke J. van der Werf +5 more
TL;DR: LTBI treatment completion can be improved by using shorter regimens and social interventions, and specific needs of the different populations with LTBI should be addressed taking into consideration the setting and condition in which the LTBI treatment programme is implemented.
Journal ArticleDOI
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Senia Rosales-Klintz,Judith Bruchfeld,Judith Bruchfeld,Walter Haas,Einar Heldal,Rein M G J Houben,Femke van Kessel,Mike Mandelbaum,Alberto Matteelli,Giovanni Battista Migliori,Anouk M. Oordt-Speets,Ivan Solovic,Martina Vasakova,Suzanne Verver,Sake J. de Vlas,Marije Vonk Noordegraaf-Schouten,Gerard de Vries,Dominik Zenner,Marieke J. van der Werf +18 more
TL;DR: The guidance elaborates on population-level measures for LTBI management tailored to the EU/EAA context and it is complementary to the WHO guidelines, and outlines the key components proposed for programmatic management of LTBI.
Journal ArticleDOI
Effectiveness of the Oral Human Attenuated Rotavirus Vaccine: A Systematic Review and Meta-analysis-2006-2016.
Corinne Willame,Marije Vonk Noordegraaf-Schouten,Emilia Gvozdenovic,Katrin Kochems,Anouk M. Oordt-Speets,Nicolas Praet,Rosa C. van Hoorn,Dominique Rosillon +7 more
TL;DR: This meta-analysis of real-world studies showed that Rotarix is effective in helping to prevent hospitalizations and/or emergency department visits due to rotavirus infection.